NIOX Group PLC is a medical device company that develops a range of therapies for asthma, chronic obstructive pulmonary disease, and allergy. The company has a single operating segment: NIOX. The NIOX segment relates to the portfolio of products used to improve asthma diagnosis and management by measuring fractional exhaled nitric oxide (FeNO). Geographically, it derives a majority of its revenue from the Asia Pacific and also has a presence in the European Union, the United States, the United Kingdom, and the Rest of the world.
2006
91
LTM Revenue $58.0M
LTM EBITDA $18.9M
$314M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
NIOX Group has a last 12-month revenue of $58.0M and a last 12-month EBITDA of $18.9M.
In the most recent fiscal year, NIOX Group achieved revenue of $55.7M and an EBITDA of $16.1M.
NIOX Group expects next 12-month revenue of XXX and NTM EBITDA of XXX
See NIOX Group valuation multiples based on analyst estimatesFY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
---|---|---|---|---|---|
Revenue | $49.0M | $55.7M | XXX | XXX | XXX |
Gross Profit | $29.6M | $35.3M | XXX | XXX | XXX |
Gross Margin | 60% | 63% | XXX | XXX | XXX |
EBITDA | $11.5M | $16.1M | XXX | XXX | XXX |
EBITDA Margin | 23% | 29% | XXX | XXX | XXX |
Net Profit | $21.5M | $14.3M | XXX | XXX | XXX |
Net Margin | 44% | 26% | XXX | XXX | XXX |
Net Debt | n/a | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 1, 2025, NIOX Group's stock price is GBP 1 (or $1).
NIOX Group has current market cap of GBP 245M (or $327M), and EV of GBP 236M (or $314M).
See NIOX Group trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$314M | $327M | XXX | XXX | XXX | XXX | $0.02 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 1, 2025, NIOX Group has market cap of $327M and EV of $314M.
NIOX Group's trades at 5.4x LTM EV/Revenue multiple, and 16.6x LTM EBITDA.
Analysts estimate NIOX Group's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for NIOX Group and 10K+ public compsFY 2024 | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|
EV | $314M | XXX | XXX | XXX |
EV/Revenue | 5.6x | XXX | XXX | XXX |
EV/EBITDA | 19.5x | XXX | XXX | XXX |
P/E | 66.3x | XXX | XXX | XXX |
P/E/Growth | 0.7x | XXX | XXX | XXX |
EV/FCF | 14.6x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialNIOX Group's NTM/LTM revenue growth is 12%
NIOX Group's revenue per employee for the last fiscal year averaged $0.6M, while opex per employee averaged $0.3M for the same period.
Over next 12 months, NIOX Group's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate NIOX Group's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for NIOX Group and other 10K+ public compsFY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|---|
Revenue Growth | 14% | XXX | XXX | XXX | XXX |
EBITDA Margin | 29% | XXX | XXX | XXX | XXX |
EBITDA Growth | 41% | XXX | XXX | XXX | XXX |
Rule of 40 (SaaS-only) | 41% | XXX | XXX | XXX | XXX |
Revenue per Employee | $0.6M | XXX | XXX | XXX | XXX |
Opex per Employee | $0.3M | XXX | XXX | XXX | XXX |
S&M Expenses to Revenue | 27% | XXX | XXX | XXX | XXX |
G&A Expenses to Revenue | 21% | XXX | XXX | XXX | XXX |
R&D Expenses to Revenue | 6% | XXX | XXX | XXX | XXX |
Opex to Revenue | 54% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
Philips | XXX | XXX | XXX | XXX | XXX | XXX |
Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
NIOX Group acquired XXX companies to date.
Last acquisition by NIOX Group was XXXXXXXX, XXXXX XXXXX XXXXXX . NIOX Group acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free TrialWhen was NIOX Group founded? | NIOX Group was founded in 2006. |
Where is NIOX Group headquartered? | NIOX Group is headquartered in United Kingdom of Great Britain and Northern Ireland. |
How many employees does NIOX Group have? | As of today, NIOX Group has 91 employees. |
Who is the CEO of NIOX Group? | NIOX Group's CEO is Mr. Jonathan Charles Emms. |
Is NIOX Group publicy listed? | Yes, NIOX Group is a public company listed on LON. |
What is the stock symbol of NIOX Group? | NIOX Group trades under NIOX ticker. |
When did NIOX Group go public? | NIOX Group went public in 2014. |
Who are competitors of NIOX Group? | Similar companies to NIOX Group include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
What is the current market cap of NIOX Group? | NIOX Group's current market cap is $327M |
What is the current revenue of NIOX Group? | NIOX Group's last 12-month revenue is $58.0M. |
What is the current EBITDA of NIOX Group? | NIOX Group's last 12-month EBITDA is $18.9M. |
What is the current EV/Revenue multiple of NIOX Group? | Current revenue multiple of NIOX Group is 5.4x. |
What is the current EV/EBITDA multiple of NIOX Group? | Current EBITDA multiple of NIOX Group is 16.6x. |
What is the current revenue growth of NIOX Group? | NIOX Group revenue growth between 2023 and 2024 was 14%. |
Is NIOX Group profitable? | Yes, NIOX Group is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.